A retrospective study sought to identify factors that correspond with occurrence of acute kidney injury in patients with hematologic cancer after high-dose methotrexate without drug monitoring.
Intensification of ADT prolonged PSA-PFS in patients with biochemically recurrent prostate cancer in a phase 3 trial.
Researchers sought to better characterize the disease features, patient characteristics, and the effects of immunodeficiency on survival among patients with plasmablastic lymphoma.
However, experts predict rise in colorectal cancer deaths in younger adults.
Results from a phase 1 trial showed that a personalized mRNA neoantigen vaccine can stimulate an immune response in patients with pancreatic ductal adenocarcinoma.
Researchers conducted a review of hospice care use to determine research outcomes and disparities among patients with cancer regarding its use.
Neoadjuvant trabectedin may be an alternative to standard chemotherapy for patients with high-grade myxoid liposarcoma of the extremities or trunk, according to researchers.
Prophylaxis with tixagevimab and cilgavimab (Evusheld) reduced the risk of breakthrough SARS-CoV-2 infections and the severity of COVID-19 among patients with hematologic cancers in an Italian study.
Metabolic changes associated with progression-free survival in patients receiving pembrolizumab.
Researchers conducted a review of hospice care use to determine research outcomes and disparities among patients with cancer regarding its use.
